Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Summary
- Eligibility
- for people ages up to 17 years (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Kristin Shimano
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Kristin Shimano
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 46 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT02464969
- Phase
- Phase 4 Venous Thromboembolism Research Study
- Study Type
- Interventional
- Participants
- Expecting 250 study participants
- Last Updated